Log In
Print
BCIQ
Print
Print this Print this
 

APD403

  Manage Alerts
Collapse Summary General Information
Company Acacia Pharma Ltd.
DescriptionIV formulation of amisulpride, an off-patent dopamine D2 and D3 receptor antagonist
Molecular Target Dopamine D2 receptor ; Dopamine D3 receptor
Mechanism of ActionDopamine D2 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationEmesis
Indication DetailsTreat and prevent chemotherapy induced nausea and vomiting (CINV)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today